Shopping Cart
- Remove All
 
Your shopping cart is currently empty
Cinpanemab (BIIB054) is a novel human monoclonal antibody with affinity for alpha-synuclein residues 1-10. Cinpanemab can be used to study Parkinson's disease and related diseases.
| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $197 | In Stock | |
| 5 mg | $516 | In Stock | |
| 10 mg | $828 | In Stock | |
| 25 mg | $1,230 | In Stock | |
| 50 mg | $1,650 | In Stock | |
| 100 mg | $2,230 | In Stock | 
| Description | Cinpanemab (BIIB054) is a novel human monoclonal antibody with affinity for alpha-synuclein residues 1-10. Cinpanemab can be used to study Parkinson's disease and related diseases.  | 
| In vitro | Cinpanemab exhibits high selectivity for aggregated forms of α-syn, with at least an 800-fold higher apparent affinity for fibrillar recombinant α-syn compared to monomeric recombinant α-syn, and it shows a strong preference for human Parkinson's disease (PD) brain tissue[2].  | 
| In vivo | Cinpanemab (30 mg/kg; intraperitoneal injection) ameliorates Parkinson's disease (PD)-like phenotypes in a mouse model inoculated with α-syn PFFs[2].  | 
| Synonyms | BIIB054 | 
| Molecular Weight | 150 kDa | 
| Cas No. | 2094516-02-4 | 
| Color | Transparent | 
| Appearance | Liquid | 
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.